Of the remaining 17 variants, all but three are accounted for by six genes (BRAF, CBL, MAP2K1, MAP2K2, RAF1, and SOS1) encoding members of the RAS-MAPK pathway, among which nine variants have previously been reported in either congenital disorders or cancer (Table 1; Supplemental Fig. S3). Here, MAP2K1 is linked to cancer.